NF‐κB and the link between inflammation and cancer

By Joseph A. DiDonato, F. Mercurio, M. Karin. Immunological Reviews, 2012

1,288 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/15723c0a3727751bb7d96951ad4848289e5136c8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Matthew Meyerson
2. Johannes A. Schmid
3. Bastian Hoesel
4. W. Garrett

In Oncology

1. E. Song
2. Johannes A. Schmid
3. Bastian Hoesel
4. W. Garrett

Citations in the corpus

• A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. (2015, background): “NF-kB is constitutively active in many tumors and considered to be a key factor in cancer development (DiDonato et al., 2012; Fornier et al., 2007).”
• The complexity of NF-κB signaling in inflammation and cancer (2013, background): “In solid tumors, in contrast, direct mutations of the NFκB signaling pathway are rare events [95].”
• Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor immune microenvironment (2013, background): “As NF-κB has been identified as a central link between inflammation and cancer (DiDonato et al., 2012), we assessed whether there was a correlation between increased NF-κB activation and Fusobacterium abundance in human colorectal cancers.”